License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Prepare all-atom structural models of PI3KC3-C1 based on the active conformation with missing regions predicted by AlphaFold-Multimer 2.2.
2
Assign protonation states to amino acid side chains based on pKa predictions by PROPKA.
Parameterize ATP
3
Parameterize a molecule of ATP in the VPS34 active site using CHARMM-GUI.
Membrane Construction
4
Construct lipid membranes consisting of DOPC (60%), DOPE (20%), DOPS (5%), and POPI (15%) using the insane method.
5
Randomly distribute coarse-grained lipids in the membrane.
Solvation and Equilibration
6
Solvate each membrane patch with 150 millimolar (mM) aqueous NaCl.
7
Perform an initial equilibration of 200 ns.
Conversion to Atomistic Representation
8
Convert the equilibrated membrane patch into an atomistic representation using the CG2AT2 tool.
Protein-Membrane System Setup
9
Place atomistic PI3KC3-C1 above the resulting membranes with a minimum distance of ~2 nm between protein and lipid atoms.
Further Equilibration
10
Subject the protein-membrane systems to an additional 10 ns of equilibration.
11
Apply harmonic positional restraints (force constant: 1000 kJ mol⁻¹ nm⁻²) to non-hydrogen protein atoms during this equilibration phase.
Production Runs
12
Perform 2 µs production runs for each of the six independent replicates of the simulation system.
13
Maintain system pressure at 1 Bar and temperature at 310 °К using the Parrinello-Rahman barostat and velocity-rescaling thermostat.
Electrostatic Interactions
14
Treat long-range electrostatic interactions using the smooth particle mesh Ewald method with charge interpolation through fourth-order B-splines.
Integration Time Step
15
Use a 2 fs integration time step for the simulations.
Bond Constraints
16
Apply the LINCS algorithm to constrain covalent bonds involving hydrogen atoms.
Steered Molecular Dynamics (SMD)
17
For SMD simulations, apply harmonic restraints (force constant: 100 kJ mol⁻¹) to reduce the center-of-mass z-distance between the protein group of interest and the membrane lipids underneath.
18
Apply a negative rate of -0.5 nm ns⁻¹ until the protein group reaches the membrane surface.
Relaxation
19
Allow the complex to relax over periods of 2 µs during further simulations upon removal of any steering force.
Preparation of membrane-engaged complex containing RAB1A
20
Superimpose the cryo-EM structure of the active-state complex including RAB1A onto the final structure of the previous MD run.
21
Model the two RAB1A geranylgeranyl groups and the VPS15 N-myristate using CHARMM-GUI.
22
Repeat above-described SMD protocol to adjust the remaining membrane interactions.
23
Allow the complex to relax for 1 µs (3 independent replicas with random velocities).